![Jason Campagna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Campagna
Directeur Technique/Scientifique/R&D chez
INVENTIVA
Profil
Jason A. Campagna currently works at Inventiva SA, as Chief Medical Officer & President-Research from 2025.
Dr. Campagna also formerly worked at Annovation BioPharma, Inc., as Director, Profibrix BV, as Managing Director, Altus Copper Corp., as Independent Director from 2021 to 2023, The Medicines Co., as Senior VP-Surgery & Perioperative Care, Intercept Pharmaceuticals, Inc., as Chief Medical Officer & Senior Vice President from 2019 to 2021, Q32 Bio, Inc., as Chief Medical Officer from 2021 to 2025, and Q32 Bio Operations, Inc., as Chief Medical Officer.
Dr. Campagna received his undergraduate degree, graduate degree, and doctorate degree from the University of Miami.
Postes actifs de Jason Campagna
| Sociétés | Poste | Début |
|---|---|---|
| INVENTIVA | Directeur Technique/Scientifique/R&D | 30/07/2025 |
Anciens postes connus de Jason Campagna
| Sociétés | Poste | Fin |
|---|---|---|
| ALTUS COPPER CORP. | Directeur/Membre du Conseil | 31/03/2023 |
| INTERCEPT PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 05/03/2021 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01/08/2016 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Directeur Technique/Scientifique/R&D | - |
Formation de Jason Campagna
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Plantable Health, Inc.
 Plantable Health, Inc. Pharmaceuticals: OtherHealth Technology Produces and sells plant-based meal products | Health Technology |
